Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
S2Medical ABOSTO:S2M -12.50% EV-to-EBITDA is -0.49 as of Aug. 27, 2026. The stock has 5 warning signs investors should review. Among 523 Medical Devices & Instruments companies, S2Medical AB ranks worse than 191204.4% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, S2Medical AB's enterprise value is kr4.34 Mil.
S2Medical AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was kr-8.90 Mil. Therefore, S2Medical AB's EV-to-EBITDA for today is -0.49.
The historical rank and industry rank for S2Medical AB's EV-to-EBITDA or its related term are showing as below:
OSTO:S2M'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -71.79 Med: -1 Max: 2.12
Current: -0.49
During the past 10 years, the highest EV-to-EBITDA of S2Medical AB was 2.12. The lowest was -71.79. And the median was -1.00.
OSTO:S2M's EV-to-EBITDA is ranked worse than 100% of 523
companies
in the Medical Devices & Instruments industry
Industry Median: 14.59
vs OSTO:S2M: -0.49
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
S2Medical AB's PE Ratio (TTM) for today is calculated as:
S2Medical AB's share price for today is kr0.0042.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. S2Medical AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.007.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for S2Medical AB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:S2M vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, S2Medical AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S2Medical AB EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where S2Medical AB's EV-to-EBITDA falls into.
S2Medical AB's current Enterprise Value is kr4.34 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. S2Medical AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was kr-8.90 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S2Medical AB (OSTO:S2M) has a EV-to-EBITDA of -0.49 as of Aug. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on S2Medical AB. According to the industry distribution chart, S2Medical AB ranks #999999 out of 523 companies in the Medical Devices & Instruments industry.
Is S2Medical AB's EV-to-EBITDA too high?
S2Medical AB's current EV-to-EBITDA is -0.49. Based on the distribution chart, S2Medical AB ranks #999999 out of 523 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does S2Medical AB's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, S2Medical AB ranks #999999 out of 523 companies for EV-to-EBITDA. This places S2Medical AB in the lower half of its industry. The industry median EV-to-EBITDA is 14.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.59, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on S2Medical AB. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S2Medical AB's current EV-to-EBITDA is -0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S2Medical AB stock overvalued right now?
Based on GuruFocus' analysis, S2Medical AB (OSTO:S2M) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.01, compared to a current price of kr0.00 — trading 58% below its estimated fair value. The current EV-to-EBITDA is -0.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For S2Medical AB (OSTO:S2M), the current EV-to-EBITDA is -0.49 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:S2M has been successfully added to your 
